阴道根治性子宫切除术治疗早期宫颈癌

IF 1.2 Q3 OBSTETRICS & GYNECOLOGY

Gynecologic Oncology Reports Pub Date : 2025-04-19 DOI:10.1016/j.gore.2025.101744

E. Bravo, J. Cartagena, C. Urbina, L. Galdames, I. Bravo, F. Núñez, A. Lehuede, A. Jara, C. Alonso, M. Pulgar

{"title":"阴道根治性子宫切除术治疗早期宫颈癌","authors":"E. Bravo, J. Cartagena, C. Urbina, L. Galdames, I. Bravo, F. Núñez, A. Lehuede, A. Jara, C. Alonso, M. Pulgar","doi":"10.1016/j.gore.2025.101744","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>The goal is to communicate the perioperative and oncological results of a single surgical team after Assisted Vaginal Radical Hysterectomy (a-VRH) for early-stage cervical cancer. We also compared these results with a control group of patients who underwent Abdominal Radical Hysterectomy (ARH) during the same period at the same center.</div></div><div><h3>Methods</h3><div>From April 2008 to November 2018, patients with early-stage cervical cancer (FIGO 1A2, 1B1, 1B2 and 2A1) were prospectively recruited to undergo surgical intervention through Radical Hysterectomy Assisted by Videolaparoscopy with Laparoscopic Systematic Pelvic Lymphadenectomy at Gustavo Fricke Hospital in Viña del Mar, Chile. This group of patients has been registered and followed up to date, analyzing epidemiological, surgical, pathological factors, and survival. We present perioperative and oncological results, along with a comparison to a similar consecutive series of 97 patients undergoing Radical Abdominal Hysterectomy (ARH) during the same period at the same center.</div></div><div><h3>Results</h3><div>Overall survival and disease-free survival in a-VRH are not inferior to those in ARH. Complications were observed in a greater proportion in ARH (16.4 % vs. 22.7 %). The hospital stay was 3.6 days for a-VRH and 6 days for ARH. Fewer transfusions were administered in the a-VRH group.</div></div><div><h3>Conclusion</h3><div>We believe that assisted a-VRH is a very good alternative for the surgical treatment of early-stage cervical cancer, as in this series of patients, the cancer outcomes are at least similar to those of ARH, allowing for the benefits of minimally invasive surgery.</div></div>","PeriodicalId":12873,"journal":{"name":"Gynecologic Oncology Reports","volume":"59 ","pages":"Article 101744"},"PeriodicalIF":1.2000,"publicationDate":"2025-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Vaginal radical hysterectomy in early stage cervical cancer\",\"authors\":\"E. Bravo, J. Cartagena, C. Urbina, L. Galdames, I. Bravo, F. Núñez, A. Lehuede, A. Jara, C. Alonso, M. Pulgar\",\"doi\":\"10.1016/j.gore.2025.101744\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>The goal is to communicate the perioperative and oncological results of a single surgical team after Assisted Vaginal Radical Hysterectomy (a-VRH) for early-stage cervical cancer. We also compared these results with a control group of patients who underwent Abdominal Radical Hysterectomy (ARH) during the same period at the same center.</div></div><div><h3>Methods</h3><div>From April 2008 to November 2018, patients with early-stage cervical cancer (FIGO 1A2, 1B1, 1B2 and 2A1) were prospectively recruited to undergo surgical intervention through Radical Hysterectomy Assisted by Videolaparoscopy with Laparoscopic Systematic Pelvic Lymphadenectomy at Gustavo Fricke Hospital in Viña del Mar, Chile. This group of patients has been registered and followed up to date, analyzing epidemiological, surgical, pathological factors, and survival. We present perioperative and oncological results, along with a comparison to a similar consecutive series of 97 patients undergoing Radical Abdominal Hysterectomy (ARH) during the same period at the same center.</div></div><div><h3>Results</h3><div>Overall survival and disease-free survival in a-VRH are not inferior to those in ARH. Complications were observed in a greater proportion in ARH (16.4 % vs. 22.7 %). The hospital stay was 3.6 days for a-VRH and 6 days for ARH. Fewer transfusions were administered in the a-VRH group.</div></div><div><h3>Conclusion</h3><div>We believe that assisted a-VRH is a very good alternative for the surgical treatment of early-stage cervical cancer, as in this series of patients, the cancer outcomes are at least similar to those of ARH, allowing for the benefits of minimally invasive surgery.</div></div>\",\"PeriodicalId\":12873,\"journal\":{\"name\":\"Gynecologic Oncology Reports\",\"volume\":\"59 \",\"pages\":\"Article 101744\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-04-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gynecologic Oncology Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2352578925000694\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologic Oncology Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352578925000694","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

目的探讨辅助阴道根治性子宫切除术（a- vrh）治疗早期宫颈癌的围手术期和肿瘤学结果。我们还将这些结果与同一时期在同一中心接受腹部根治性子宫切除术（ARH）的对照组患者进行了比较。方法2008年4月至2018年11月，前瞻性招募早期宫颈癌（FIGO 1A2、1B1、1B2和2A1）患者，在智利Viña del Mar Gustavo Fricke医院行腹腔镜下盆腔淋巴结切除术辅助根治性子宫切除术。本组患者已登记并随访至今，分析流行病学、手术、病理因素和生存率。我们报告了围手术期和肿瘤学结果，并与同一时期在同一中心接受根治性腹部子宫切除术（ARH）的97例类似连续系列患者进行了比较。结果a-VRH的总生存期和无病生存期不低于ARH。并发症在ARH中所占比例更高（16.4%比22.7%）。a-VRH的住院时间为3.6天，ARH的住院时间为6天。a-VRH组输血较少。结论我们认为辅助a- vrh是早期宫颈癌手术治疗的一个很好的选择，因为在这一系列患者中，癌症结局至少与ARH相似，可以获得微创手术的好处。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Vaginal radical hysterectomy in early stage cervical cancer

Objectives

The goal is to communicate the perioperative and oncological results of a single surgical team after Assisted Vaginal Radical Hysterectomy (a-VRH) for early-stage cervical cancer. We also compared these results with a control group of patients who underwent Abdominal Radical Hysterectomy (ARH) during the same period at the same center.

Methods

From April 2008 to November 2018, patients with early-stage cervical cancer (FIGO 1A2, 1B1, 1B2 and 2A1) were prospectively recruited to undergo surgical intervention through Radical Hysterectomy Assisted by Videolaparoscopy with Laparoscopic Systematic Pelvic Lymphadenectomy at Gustavo Fricke Hospital in Viña del Mar, Chile. This group of patients has been registered and followed up to date, analyzing epidemiological, surgical, pathological factors, and survival. We present perioperative and oncological results, along with a comparison to a similar consecutive series of 97 patients undergoing Radical Abdominal Hysterectomy (ARH) during the same period at the same center.

Results

Overall survival and disease-free survival in a-VRH are not inferior to those in ARH. Complications were observed in a greater proportion in ARH (16.4 % vs. 22.7 %). The hospital stay was 3.6 days for a-VRH and 6 days for ARH. Fewer transfusions were administered in the a-VRH group.

Conclusion

We believe that assisted a-VRH is a very good alternative for the surgical treatment of early-stage cervical cancer, as in this series of patients, the cancer outcomes are at least similar to those of ARH, allowing for the benefits of minimally invasive surgery.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Gynecologic Oncology Reports OBSTETRICS & GYNECOLOGY-

CiteScore

2.00

自引率

0.00%

发文量

183

审稿时长

41 days

期刊介绍： Gynecologic Oncology Reports is an online-only, open access journal devoted to the rapid publication of narrative review articles, survey articles, case reports, case series, letters to the editor regarding previously published manuscripts and other short communications in the field of gynecologic oncology. The journal will consider papers that concern tumors of the female reproductive tract, with originality, quality, and clarity the chief criteria of acceptance.